Pharmaceuticals, Biotechnology and Life Sciences
Imsidolimab demonstrated rapid and sustained efficacy with 6 of 8 (75%) generalized pustular psoriasis (GPP) patients achieving the primary endpoint…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing…
Preliminary clinical data from Phase 1/2 study still anticipated in Q4SAN MATEO, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE…
CAMBRIDGE, Mass. and NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology…
HOUSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines…
SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation…
Company to host conference call and webcast Thursday, October 7, 2021, at 9:00 a.m. ETSOUTH SAN FRANCISCO, Calif. and SAN…
BOSTON, Sept. 30, 2021 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue…
Management to host webcast and conference call on October 7 at 8 a.m. ETSAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE)…
The KN-8701 trial is a multi-center, open-label, two-part trial of Kinnate’s lead RAF inhibitor candidate KIN-2787SAN FRANCISCO and SAN DIEGO,…